BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sartorius R, Trovato M, Manco R, D'Apice L, De Berardinis P. Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines. NPJ Vaccines 2021;6:127. [PMID: 34711839 DOI: 10.1038/s41541-021-00391-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang N, Tan Z, Wei J, Zhang S, Liu Y, Miao Y, Ding Q, Yi W, Gan M, Li C, Liu B, Wang H, Zheng Z. Identification of novel anti-ZIKV drugs from viral-infection temporal gene expression profiles. Emerg Microbes Infect 2023;12:2174777. [PMID: 36715162 DOI: 10.1080/22221751.2023.2174777] [Reference Citation Analysis]
2 Zhao D, Chen X, Wang L, Zhang J, Zhao Z, Yue N, Zhu Y, Fei W, Li X, Tan L, He W. Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine. Int J Biol Macromol 2023;234:123635. [PMID: 36801224 DOI: 10.1016/j.ijbiomac.2023.123635] [Reference Citation Analysis]
3 Choudhary SA, Patra D, Sinha A, Mazumder S, Pant R, Chouhan R, Jha AN, Prusty BM, Manna D, Das SK, Tikoo K, Pal D, Dasgupta S. A small molecule potent IRAK4 inhibitor abrogates lipopolysaccharide-induced macrophage inflammation in-vitro and in-vivo. Eur J Pharmacol 2023;944:175593. [PMID: 36804543 DOI: 10.1016/j.ejphar.2023.175593] [Reference Citation Analysis]
4 Atiyah NS, Fadhil HY, Ad'hiah AH. Toll-like receptor 10 is down-regulated in serum of patients with relapsing-remitting multiple sclerosis but not associated with Epstein-Barr virus. J Neurovirol 2023. [PMID: 36934201 DOI: 10.1007/s13365-023-01124-4] [Reference Citation Analysis]
5 Tan C, Zhu F, Pan P, Wu A, Li C. Development of multi-epitope vaccines against the monkeypox virus based on envelope proteins using immunoinformatics approaches. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1112816] [Reference Citation Analysis]
6 Chen S, Pounraj S, Sivakumaran N, Kakkanat A, Sam G, Kabir MT, Rehm BHA. Precision-engineering of subunit vaccine particles for prevention of infectious diseases. Front Immunol 2023;14:1131057. [PMID: 36817419 DOI: 10.3389/fimmu.2023.1131057] [Reference Citation Analysis]
7 Gao X, Xia Y, Liu X, Xu Y, Lu P, Dong Z, Liu J, Liang G. A perspective on SARS-CoV-2 virus-like particles vaccines. Int Immunopharmacol 2023;115:109650. [PMID: 36649673 DOI: 10.1016/j.intimp.2022.109650] [Reference Citation Analysis]
8 Xin J. Critical signaling pathways governing colitis-associated colorectal cancer: Signaling, therapeutic implications, and challenges. Dig Liver Dis 2023;55:169-77. [PMID: 36002360 DOI: 10.1016/j.dld.2022.08.012] [Reference Citation Analysis]
9 Saleki K, Razi S, Rezaei N. Infection and Immunity. Clinical Immunology 2023. [DOI: 10.1016/b978-0-12-818006-8.00007-4] [Reference Citation Analysis]
10 Labarrere CA, Kassab GS. Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease. Front Microbiol 2022;13:979719. [DOI: 10.3389/fmicb.2022.979719] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ko C, Zang S, Zhou Y, Zhong Z, Yang C. Nanocarriers for effective delivery: modulation of innate immunity for the management of infections and the associated complications. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01582-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Nitika, Wei J, Hui AM. The Delivery of mRNA Vaccines for Therapeutics. Life (Basel) 2022;12:1254. [PMID: 36013433 DOI: 10.3390/life12081254] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Nilsen KE, Skjesol A, Frengen Kojen J, Espevik T, Stenvik J, Yurchenko M. TIRAP/Mal Positively Regulates TLR8-Mediated Signaling via IRF5 in Human Cells. Biomedicines 2022;10:1476. [DOI: 10.3390/biomedicines10071476] [Reference Citation Analysis]
14 Osterloh A. Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria. Vaccines 2022;10:751. [DOI: 10.3390/vaccines10050751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Neves F, Marques JP, Areal H, Pinto-Pinho P, Colaço B, Melo-Ferreira J, Fardilha M, Abrantes J, Esteves PJ. TLR7 and TLR8 evolution in lagomorphs: different patterns in the different lineages. Immunogenetics 2022. [PMID: 35419618 DOI: 10.1007/s00251-022-01262-9] [Reference Citation Analysis]
16 Zhou SH, Li YT, Zhang RY, Liu YL, You ZW, Bian MM, Wen Y, Wang J, Du JJ, Guo J. Alum Adjuvant and Built-in TLR7 Agonist Synergistically Enhance Anti-MUC1 Immune Responses for Cancer Vaccine. Front Immunol 2022;13:857779. [PMID: 35371101 DOI: 10.3389/fimmu.2022.857779] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Schilling E, Pfeiffer L, Hauschildt S, Koehl U, Claus C. CD14 Is Involved in the Interferon Response of Human Macrophages to Rubella Virus Infection. Biomedicines 2022;10:266. [DOI: 10.3390/biomedicines10020266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Tariq H, Batool S, Asif S, Ali M, Abbasi BH. Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases. Front Microbiol 2021;12:790121. [PMID: 35046918 DOI: 10.3389/fmicb.2021.790121] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
19 Guo-Parke H, Linden D, Weldon S, Kidney JC, Taggart CC. Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium. Medicina (Kaunas) 2022;58:121. [PMID: 35056429 DOI: 10.3390/medicina58010121] [Reference Citation Analysis]
20 Kumar V, Barrett JE. Toll-Like Receptors (TLRs) in Health and Disease: An Overview. Toll-like Receptors in Health and Disease 2022. [DOI: 10.1007/164_2021_568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wade H, Duan Q, Su Q. Interaction between Sars-CoV-2 structural proteins and host cellular receptors: From basic mechanisms to clinical perspectives. Adv Protein Chem Struct Biol 2022;132:243-77. [PMID: 36088078 DOI: 10.1016/bs.apcsb.2022.05.010] [Reference Citation Analysis]